Condensed Financial Information of Parent Company (Tables)

12 Months Ended

Dec. 31, 2024

Condensed Financial Information Disclosure [Abstract]

Schedule of Parent-only Balance Sheets

The following table presents the parent-only balance sheets of GoodRx Holdings, Inc.:

(in thousands, except par values)	December 31, 2024	December 31, 2023
Assets
Cash	$30	$5
Other assets	—	164
Investment in subsidiary, net of distributions	724,628	761,790
Total assets	$724,658	$761,959
Liabilities and stockholders' equity
Total liabilities	$—	$1
Stockholders' equity
Preferred stock, $0.0001 par value	—	—
Common stock, $0.0001 par value	38	40
Additional paid-in capital	2,165,633	2,219,321
Accumulated deficit	(1,441,013)	(1,457,403)
Total stockholders' equity	724,658	761,958
Total liabilities and stockholders' equity	$724,658	$761,959

Schedule of Parent-only Statement of Operations

The following table presents the parent-only statements of operations of GoodRx Holdings, Inc.:

	Year Ended December 31,
(in thousands)	2024	2023	2022
Equity in earnings (loss) of subsidiary	$16,390	$(8,868)	$(32,828)
Net income (loss)	$16,390	$(8,868)	$(32,828)

Schedule of Parent-only Statement of Cash Flows

The following table presents the parent-only statements of cash flows of GoodRx Holdings, Inc.:

	Year Ended December 31,
(in thousands)	2024	2023	2022
Cash flows from operating activities
Net income (loss)	$16,390	$(8,868)	$(32,828)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Equity in (earnings) loss of subsidiary	(16,390)	8,868	32,828
Changes in assets and liabilities:
Other assets	164	(164)	80
Other current liabilities	(1)	1	—
Net cash provided by (used in) operating activities	163	(163)	80
Cash flows from investing activities
Distribution from subsidiary	167,679	162,287	113,117
Net cash provided by investing activities	167,679	162,287	113,117
Cash flows from financing activities
Repurchases of Class A common stock	(158,845)	(103,974)	(101,721)
Proceeds from exercise of stock options	19,046	5,941	9,159
Employee taxes paid related to net share settlement of equity awards	(29,784)	(65,481)	(20,635)
Proceeds from employee stock purchase plan	1,766	1,390	—
Net cash used in financing activities	(167,817)	(162,124)	(113,197)
Net change in cash	25	—	—
Cash
Beginning of period	5	5	5
End of period	$30	$5	$5